According to our (Global Info Research) latest study, the global Microbial Polysaccharides market size was valued at US$ 2504 million in 2025 and is forecast to a readjusted size of US$ 3401 million by 2032 with a CAGR of 4.5% during review period.
Microbial polysaccharides are high molecular weight carbohydrates produced by microorganisms such as bacteria, fungi, yeast, and algae. At present, microbial polysaccharides that have been industrially produced mainly include xanthan gum, gellan gum, dextran, pullulan, and curdlan gum.
Upstream, microbial polysaccharides depend on fermentable carbon sources (glucose, sucrose, starch hydrolysates, molasses, whey permeate, glycerol), nitrogen sources and minerals, high-performance microbial strains, and stainless-steel or glass-lined fermenters plus downstream equipment for separation, purification and drying. Downstream, these polysaccharides are used as thickeners, stabilizers, gelling agents, film-formers, emulsifiers and bioactive materials in food & beverages, pharmaceuticals (plasma expanders, controlled-release matrices, wound dressings), cosmetics & personal care, oil & gas drilling fluids, construction, mining, agriculture (biostimulants, soil conditioners) and emerging biomedical and packaging applications.
In 2024, global sales of microbial polysaccharides reached approximately 440 K tons, with an average global market price of around US$5,286/ton. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 25% to 50%.
Overall, the market for microbial polysaccharides is in a phase of steady expansion, with core demand concentrated in high-volume segments such as food and beverages, personal care and household products. As clean-label, plant-based and low-sugar/low-fat trends strengthen, xanthan gum, gellan gum, pullulan and related polysaccharides are increasingly viewed as key alternatives to gelatin, modified starches and certain synthetic hydrocolloids; they provide the required viscosity, suspension and gel structure while allowing brand owners to simplify ingredient lists and reduce formulation load without sacrificing sensory quality and shelf stability. In parallel, continuous upgrades in fermentation process design and process control are improving productivity and batch-to-batch consistency, underpinning both the cost and quality competitiveness of these bio-based polymers.
In pharmaceutical and biomedical fields, the strategic relevance of microbial polysaccharides is becoming more pronounced. Numerous studies indicate that exopolysaccharides exhibit excellent biocompatibility and degradability, together with a wide range of bioactivities such as immunomodulation, antioxidant effects and promotion of tissue repair, which gives them clear advantages in drug-controlled-release matrices, tissue-engineering scaffolds, wound dressings, cell encapsulation and three-dimensional culture systems. As demand rises for advanced formulations, regenerative medicine and precision therapies, high-purity grades of dextran, curdlan, pullulan and modified EPS are progressively penetrating high-value medical and health-care applications, becoming a key driver for the industry’s move up the value chain.
At the same time, the market still faces several structural challenges and directions for evolution. On one hand, compared with starch-based and some synthetic polymers, microbial polysaccharides typically require longer fermentation cycles and more complex downstream purification, which makes certain products relatively cost-sensitive in bulk industrial uses; this is pushing producers to raise volumetric productivity, valorize by-products and adopt lower-cost carbon sources in order to relieve cost pressure. On the other hand, tightening environmental and regulatory expectations are encouraging companies to reinforce their sustainability strategies, including the use of agricultural residues or by-products as substrates, reduction of organic-solvent usage, and development of polysaccharide-based materials that are easier to recycle and biodegrade. Overall, microbial polysaccharides are expected to evolve along a path of “structure designability – application specialization – green production”, with the market structure gradually stabilizing into a balance between integrated leaders and specialized players focused on narrow but high-value niches.
This report is a detailed and comprehensive analysis for global Microbial Polysaccharides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microbial Polysaccharides market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbial Polysaccharides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbial Polysaccharides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fufeng Group, Meihua Group, CP Kelco, Deosen Biochemical, Pharmacosmos, Magle Biopolymers, Nagase Viita, Jianlong Biotechnology, Jungbunzlauer, Cargill, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Microbial Polysaccharides market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Xanthan Gum
Gellan Gum
Dextran
Pullulan
Curdlan Gum
Other
Market segment by Producing Organism
Bacterial
Fungal
Yeast-derived
Microalgal
Market segment by Ionic Charge
Anionic
Neutral
Cationic
Market segment by Application
Food & Beverage
Pharmaceuticals & Biomedical
Cosmetics & Personal Care
Petroleum
Other
Major players covered
Fufeng Group
Meihua Group
CP Kelco
Deosen Biochemical
Pharmacosmos
Magle Biopolymers
Nagase Viita
Jianlong Biotechnology
Jungbunzlauer
Cargill
IFF
DSM
Meito Sangyo
Polydex Pharmaceuticals
Organo Food Tech Corporation
Mitsubishi Corporation Life Sciences
Hebei Xinhe Biochemical
Dancheng Caixin Sugar Industry
Zhejiang Tech-Way Biotechnology
Shandong Freda Biotechnology
Shandong Kangnaxin Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microbial Polysaccharides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Microbial Polysaccharides, with price, sales quantity, revenue, and global market share of Microbial Polysaccharides from 2021 to 2026.
Chapter 3, the Microbial Polysaccharides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microbial Polysaccharides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Microbial Polysaccharides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Microbial Polysaccharides.
Chapter 14 and 15, to describe Microbial Polysaccharides sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Microbial Polysaccharides. Industry analysis & Market Report on Microbial Polysaccharides is a syndicated market report, published as Global Microbial Polysaccharides Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Microbial Polysaccharides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.